The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Gladell P. Paner and Russell Z. Szmulewitz.
Connection Strength

0.347
  1. Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report. Front Oncol. 2015; 5:169.
    View in: PubMed
    Score: 0.136
  2. Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 2022 Feb; 41(8):1234.
    View in: PubMed
    Score: 0.053
  3. SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 2022 02; 41(8):1190-1202.
    View in: PubMed
    Score: 0.053
  4. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res. 2018 08 01; 24(15):3668-3680.
    View in: PubMed
    Score: 0.041
  5. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
    View in: PubMed
    Score: 0.036
  6. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One. 2013; 8(1):e53701.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.